Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2025 06:00 ET | Source: AscellaHealth, LLC

AscellaHealth Supports Rare Disease Patients and Caregivers in Observance of Rare Disease Day, February 28

AscellaHealth Commemorates Rare Disease Day, February 28, by Supporting Patients and Caregivers"
November 11, 2024 08:00 ET | Source: Annovis Bio, Inc.

Annovis Bio Reports Third Quarter Financial Results and Provides Business Update

MALVERN, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for...
June 27, 2023 07:00 ET | Source: BIOXYTRAN, INC.

Bioxytran Peer-Reviewed Journal in “Vaccines” Contains Mechanism Capable of Targeting Future COVID-19 Mutations

Complete elimination of viral load in 100% of patients at day 7 vs 6% in placebo (p=.001)Complete elimination of most symptoms by day 7Galectin antagonist acts as an entry inhibitor for use in...
May 24, 2023 10:12 ET | Source: Curative Biotechnology, Inc. 

Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation

Topical Administration Capable of Delivering Metformin to Choroid, RPE, and Retina Boca Raton, FL, May 24, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or...
December 14, 2022 07:00 ET | Source: BIOXYTRAN, INC.

Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization

BOSTON, MASSACHUSETTS, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19...
December 08, 2022 07:00 ET | Source: BIOXYTRAN, INC.

Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients

BOSTON, MASSACHUSETTS, Dec. 08, 2022 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and...
July 15, 2021 10:00 ET | Source: Curative Biotechnology, Inc. 

Curative Biotechnology, Inc. Appoints Marc Drimer, CPA to Board of Directors as Independent Director and Chairman of Audit Committee

Boca Raton, FL, July 15, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development stage biomedical company focused on novel therapies for...